CVE-2023-38888
Cross Site Scripting vulnerability in Dolibarr ERP CRM v.17.0.1 and before allows a remote attacker to obtain sensitive information and execute arbitrary code via the REST API module, related to analyseVarsForSqlAndScriptsInjection and…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (1.12%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Cross Site Scripting vulnerability in Dolibarr ERP CRM v.17.0.1 and before allows a remote attacker to obtain sensitive information and execute arbitrary code via the REST API module, related to analyseVarsForSqlAndScriptsInjection and testSqlAndScriptInject.
- CVSS 3.1
- 9.6 CRITICALCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:H
- EPSS
- 1.12% probability · 64th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-79
- Affected
- dolibarr/dolibarr erp\/crm
- Source
- cve@mitre.org
References
- https://akerva.com/wp-content/uploads/2023/09/AKERVA_Security-Advisory_CVE-2023-38888_Dolibarr_XSS.pdfExploit, Third Party Advisory
- https://akerva.com/wp-content/uploads/2023/09/AKERVA_Security-Advisory_CVE-2023-38888_Dolibarr_XSS.pdfExploit, Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.